Treatment with autologous antigen-presenting cells activated with the HER-2 based antigen Lapuleucel-T: results of a phase I study in immunologic and clinical activity in HER-2 overexpressing breast cancer
(Q46108775)
scientific article published in August 2007
scientific article published in August 2007
Language: